OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Routes of administration for cannabis use – basic prevalence and related health outcomes: A scoping review and synthesis
Cayley Russell, Sergio Rueda, Robin Room, et al.
International Journal of Drug Policy (2017) Vol. 52, pp. 87-96
Closed Access | Times Cited: 253

Showing 1-25 of 253 citing articles:

Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: Findings from state policy evaluations
Rosanna Smart, Rosalie Liccardo Pacula
The American Journal of Drug and Alcohol Abuse (2019) Vol. 45, Iss. 6, pp. 644-663
Open Access | Times Cited: 243

Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis
Tory R. Spindle, Edward J. Cone, Nicolas J. Schlienz, et al.
JAMA Network Open (2018) Vol. 1, Iss. 7, pp. e184841-e184841
Open Access | Times Cited: 208

Changing landscape of cannabis: novel products, formulations, and methods of administration
Tory R. Spindle, Marcel O. Bonn‐Miller, Ryan G. Vandrey
Current Opinion in Psychology (2019) Vol. 30, pp. 98-102
Open Access | Times Cited: 193

Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets
Samantha Goodman, Elle Wadsworth, Cesar Leos‐Toro, et al.
International Journal of Drug Policy (2020) Vol. 76, pp. 102658-102658
Closed Access | Times Cited: 155

Cannabis and its derivatives
Gangotri Debbarma, Pratap Chandra Acharya
Elsevier eBooks (2024), pp. 37-91
Closed Access | Times Cited: 146

Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update
Benedikt Fischer, Tessa Robinson, Chris Bullen, et al.
International Journal of Drug Policy (2021) Vol. 99, pp. 103381-103381
Open Access | Times Cited: 130

ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids
Shalini Shah, Eric S. Schwenk, Rakesh V. Sondekoppam, et al.
Regional Anesthesia & Pain Medicine (2023) Vol. 48, Iss. 3, pp. 97-117
Open Access | Times Cited: 57

Evaluating the impacts of cannabis legalization: The International Cannabis Policy Study
David Hammond, Samantha Goodman, Elle Wadsworth, et al.
International Journal of Drug Policy (2020) Vol. 77, pp. 102698-102698
Closed Access | Times Cited: 129

Types of cannabis and tobacco/nicotine co-use and associated outcomes in young adulthood.
Joan S. Tucker, Eric R. Pedersen, Rachana Seelam, et al.
Psychology of Addictive Behaviors (2019) Vol. 33, Iss. 4, pp. 401-411
Open Access | Times Cited: 110

Medical cannabis use in the Australian community following introduction of legal access: the 2018–2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)
Nicholas Lintzeris, Llewellyn Mills, Anastasia Suraev, et al.
Harm Reduction Journal (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 104

Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant
Elaine Cristina Dalazen Gonçalves, Gabriela Mantovani Baldasso, Maíra A. Bicca, et al.
Molecules (2020) Vol. 25, Iss. 7, pp. 1567-1567
Open Access | Times Cited: 91

Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid
Tory R. Spindle, Edward J. Cone, Nicolas J. Schlienz, et al.
Journal of Analytical Toxicology (2018) Vol. 43, Iss. 4, pp. 233-258
Open Access | Times Cited: 89

Oral and periodontal implications of tobacco and nicotine products
Benjamin W. Chaffee, Elizabeth T. Couch, Manali V. Vora, et al.
Periodontology 2000 (2021) Vol. 87, Iss. 1, pp. 241-253
Open Access | Times Cited: 89

Sex differences in the acute effects of oral and vaporized cannabis among healthy adults
Dennis J. Sholler, Justin C. Strickland, Tory R. Spindle, et al.
Addiction Biology (2020) Vol. 26, Iss. 4
Open Access | Times Cited: 85

Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses
Zeinab Breijyeh, Buthaina Jubeh, Sabino Aurelio Bufo, et al.
Toxins (2021) Vol. 13, Iss. 2, pp. 117-117
Open Access | Times Cited: 84

Communicating THC levels and ‘dose’ to consumers: Implications for product labelling and packaging of cannabis products in regulated markets
David Hammond
International Journal of Drug Policy (2019) Vol. 91, pp. 102509-102509
Closed Access | Times Cited: 81

Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis
Graziella Filippini, Silvia Minozzi, Francesca Borrelli, et al.
Cochrane library (2022)
Open Access | Times Cited: 49

Prevalence and use of cannabis products and routes of administration among youth and young adults in Canada and the United States: A systematic review
Elle Wadsworth, Sam Craft, Robert Calder, et al.
Addictive Behaviors (2022) Vol. 129, pp. 107258-107258
Closed Access | Times Cited: 45

Cannabis Use Disorder and Perioperative Complications
Paul Potnuru, Srikar Jonna, George W. Williams
JAMA Surgery (2023) Vol. 158, Iss. 9, pp. 935-935
Closed Access | Times Cited: 25

Cannabis use in Germany: Frequency, routes of administration, and co-use of inhaled nicotine or tobacco products
Daniel Kotz, Sabrina Kastaun, Jakob Manthey, et al.
Deutsches Ärzteblatt international (2024)
Open Access | Times Cited: 9

How will cannabis legalization affect health, safety, and social equity outcomes? It largely depends on the 14 Ps
Beau Kilmer
The American Journal of Drug and Alcohol Abuse (2019) Vol. 45, Iss. 6, pp. 664-672
Open Access | Times Cited: 65

Cannabis use disorder and the lungs
Kathryn Gracie, Robert J. Hancox
Addiction (2020) Vol. 116, Iss. 1, pp. 182-190
Closed Access | Times Cited: 65

Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis
Nicolas J. Schlienz, Tory R. Spindle, Edward J. Cone, et al.
Drug and Alcohol Dependence (2020) Vol. 211, pp. 107969-107969
Open Access | Times Cited: 62

The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda
Mallory Loflin, Brian D. Kiluk, Marilyn A. Huestis, et al.
Drug and Alcohol Dependence (2020) Vol. 212, pp. 107993-107993
Open Access | Times Cited: 56

Page 1 - Next Page

Scroll to top